Sobel Alan D.

Insider profile

Performance

Overall performance
1.3

Performance over holding periods
1.3
30 days 90 days 120 days
Average return -14% 8.2% 15.1%
Success rate 40% 68% 82%
Transactions
3 100% Buy
34 71% Buy
47 69% Buy
Sobel Alan D.'s trades of Cytosorbents Corp's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
413.05
Quantity 49,931 +15.5%
Value US$188,076
Transaction date
Purchase
Price
130.26
Quantity 1,814 +45.9%
Value US$3,070,574
Transaction date
Purchase
Price
144.54
Quantity 30,076 +32.0%
Value US$4,573,986
Transaction date
Purchase
Price
1.33
Quantity 22,557 +28.4%
Value US$30,001
Transaction date
Purchase
Price
2.02
Quantity 8,800 +12.5%
Value US$17,776
Transaction date
Purchase
Price
2.00
Quantity 1,200 +1.7%
Value US$2,399
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-09-16 2026-09-15 B Purchase
49,931 +15.5%
413.05
US$188,076
49,931 +15.5% 413.05 US$188,076
2026-09-16 2026-09-15 B Purchase
1,814 +45.9%
130.26
US$3,070,574
1,814 +45.9% 130.26 US$3,070,574
2026-09-16 2026-09-15 B Purchase
30,076 +32.0%
144.54
US$4,573,986
30,076 +32.0% 144.54 US$4,573,986
2023-12-15 2023-12-13 B Purchase
22,557 +28.4%
1.33
US$30,001
22,557 +28.4% 1.33 US$30,001
2022-05-12 2022-05-11 B Purchase
8,800 +12.5%
2.02
US$17,776
8,800 +12.5% 2.02 US$17,776
2022-05-12 2022-05-11 B Purchase
1,200 +1.7%
2.00
US$2,399
1,200 +1.7% 2.00 US$2,399